Thomas Böldicke

816 total citations
32 papers, 632 citations indexed

About

Thomas Böldicke is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Thomas Böldicke has authored 32 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Immunology. Recurrent topics in Thomas Böldicke's work include Monoclonal and Polyclonal Antibodies Research (17 papers), Glycosylation and Glycoproteins Research (6 papers) and CAR-T cell therapy research (4 papers). Thomas Böldicke is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (17 papers), Glycosylation and Glycoproteins Research (6 papers) and CAR-T cell therapy research (4 papers). Thomas Böldicke collaborates with scholars based in Germany, United States and Canada. Thomas Böldicke's co-authors include Stefan Dübel, Andrea L. J. Marschall, Joël Gautron, M. Panhéleux, Yves Y. Nys, Maxwell T. Hincke, Juan Manuel García‐Ruiz, Michael Böcher, Michael Kieß and Ursula Bilitewski and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and The Science of The Total Environment.

In The Last Decade

Thomas Böldicke

32 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Böldicke Germany 13 326 214 126 98 96 32 632
Holger Kayser Germany 6 572 1.8× 102 0.5× 71 0.6× 65 0.7× 24 0.3× 8 650
Say Kong Ng Singapore 19 873 2.7× 246 1.1× 86 0.7× 102 1.0× 22 0.2× 39 1.1k
Sudhir Sahdev India 11 496 1.5× 67 0.3× 214 1.7× 75 0.8× 22 0.2× 14 833
Arthur H. Hale United States 14 270 0.8× 94 0.4× 231 1.8× 46 0.5× 40 0.4× 51 608
E J Nichols United States 13 324 1.0× 100 0.5× 102 0.8× 50 0.5× 6 0.1× 15 684
Elizabeth Diblasio United States 4 650 2.0× 198 0.9× 134 1.1× 103 1.1× 7 0.1× 5 915
Pam M. Dando United Kingdom 10 629 1.9× 55 0.3× 249 2.0× 354 3.6× 24 0.3× 10 1.2k
Gonzalo González de Buitrago Spain 20 725 2.2× 41 0.2× 314 2.5× 186 1.9× 36 0.4× 30 1.3k
Leslie Evans United Kingdom 15 755 2.3× 426 2.0× 105 0.8× 161 1.6× 7 0.1× 19 1.2k

Countries citing papers authored by Thomas Böldicke

Since Specialization
Citations

This map shows the geographic impact of Thomas Böldicke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Böldicke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Böldicke more than expected).

Fields of papers citing papers by Thomas Böldicke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Böldicke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Böldicke. The network helps show where Thomas Böldicke may publish in the future.

Co-authorship network of co-authors of Thomas Böldicke

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Böldicke. A scholar is included among the top collaborators of Thomas Böldicke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Böldicke. Thomas Böldicke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ajay, Amrendra K., Martin Gasser, Li‐Li Hsiao, Thomas Böldicke, & Ana Maria Waaga-Gasser. (2024). TLR2 and TLR9 Blockade Using Specific Intrabodies Inhibits Inflammation-Mediated Pancreatic Cancer Cell Growth. Antibodies. 13(1). 11–11. 6 indexed citations
2.
Waaga-Gasser, Ana Maria & Thomas Böldicke. (2024). Genetically Engineered T Cells and Recombinant Antibodies to Target Intracellular Neoantigens: Current Status and Future Directions. International Journal of Molecular Sciences. 25(24). 13504–13504. 2 indexed citations
3.
Böldicke, Thomas. (2022). Therapeutic Potential of Intrabodies for Cancer Immunotherapy: Current Status and Future Directions. Antibodies. 11(3). 49–49. 14 indexed citations
4.
Büssow, Konrad, Mario Köster, Rainer Zawatzky, et al.. (2019). ER intrabody-mediated inhibition of interferon α secretion by mouse macrophages and dendritic cells. PLoS ONE. 14(4). e0215062–e0215062. 5 indexed citations
5.
Marschall, Andrea L. J., Stefan Dübel, & Thomas Böldicke. (2016). Recent Advances with ER Targeted Intrabodies. Advances in experimental medicine and biology. 917. 77–93. 13 indexed citations
6.
Böldicke, Thomas. (2016). Protein Targeting Compounds. Advances in experimental medicine and biology. 1 indexed citations
7.
Bauer, Stefan, et al.. (2013). Molecular cloning and characterization of a novel anti-TLR9 intrabody. Cellular & Molecular Biology Letters. 18(3). 433–46. 10 indexed citations
8.
Böldicke, Thomas, et al.. (2013). Construction, expression and binding specificity of bispecific CD3 × VEGFR-2 and CD3 × NCAM antibodies in the single chain and diabody format. Advances in Bioscience and Biotechnology. 4(5). 654–664. 1 indexed citations
9.
Böldicke, Thomas, et al.. (2011). Functional inhibition of transitory proteins by intrabody-mediated retention in the endoplasmatic reticulum. Methods. 56(3). 338–350. 8 indexed citations
10.
Kirschning, Carsten J., Stefan Dreher, J Schade, et al.. (2010). Generation of anti-TLR2 intrabody mediating inhibition of macrophage surface TLR2 expression and TLR2-driven cell activation. BMC Biotechnology. 10(1). 31–31. 18 indexed citations
11.
Böldicke, Thomas. (2007). Blocking translocation of cell surface molecules from the ER to the cell surface by intracellular antibodies targeted to the ER. Journal of Cellular and Molecular Medicine. 11(1). 54–70. 34 indexed citations
12.
Böldicke, Thomas, Holger Weber, Peter P. Mueller, Bernhard Barleon, & María José Bernal. (2005). Novel highly efficient intrabody mediates complete inhibition of cell surface expression of the human vascular endothelial growth factor receptor-2 (VEGFR-2/KDR). Journal of Immunological Methods. 300(1-2). 146–159. 25 indexed citations
13.
Gautron, Joël, Maxwell T. Hincke, M. Panhéleux, et al.. (2001). Ovotransferrin is a Matrix Protein of the Hen Eggshell Membranes and Basal Calcified Layer. Connective Tissue Research. 42(4). 255–267. 124 indexed citations
14.
Böldicke, Thomas, Friedhelm Struck, Fred Schaper, et al.. (2000). A new peptide-affinity tag for the detection and affinity purification of recombinant proteins with a monoclonal antibody. Journal of Immunological Methods. 240(1-2). 165–183. 12 indexed citations
15.
Böcher, Michael, Thomas Böldicke, Michael Kieß, & Ursula Bilitewski. (1997). Synthesis of mono- and bifunctional peptide–dextran conjugates for the immobilization of peptide antigens on ELISA plates: properties and application. Journal of Immunological Methods. 208(2). 191–202. 41 indexed citations
16.
Böldicke, Thomas, et al.. (1995). Human Monoclonal Antibodies to Cytomegalovirus. European Journal of Biochemistry. 234(2). 397–405. 2 indexed citations
17.
Böcher, Michael, Thomas Böldicke, & Florenz Sasse. (1993). Cytotoxic effect of atrazine on murine B-lymphocytes in vitro. The Science of The Total Environment. 132(2-3). 429–433. 6 indexed citations
18.
Böldicke, Thomas, et al.. (1993). In vitro immunization of mouse spleen cells for the production of monoclonal IgG1 antibodies using an antigen-specific T helper cell clone (D.10.G4.1). Journal of Immunological Methods. 166(2). 165–175. 12 indexed citations
19.
Arias, Ariel E., Thomas Böldicke, & Moı̈se Bendayan. (1993). Absence of trypsinogen autoactivation and immunolocalization of pancreatic secretory trypsin inhibitor in acinar cells in vitro. In Vitro Cellular & Developmental Biology - Animal. 29(3). 221–227. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Holger Kayser Breakdown of academic impact, for papers by Say Kong Ng Breakdown of academic impact, for papers by Sudhir Sahdev Breakdown of academic impact, for papers by Arthur H. Hale Breakdown of academic impact, for papers by E J Nichols Breakdown of academic impact, for papers by Elizabeth Diblasio Breakdown of academic impact, for papers by Pam M. Dando Breakdown of academic impact, for papers by Gonzalo González de Buitrago Breakdown of academic impact, for papers by Leslie Evans
Rankless by CCL
2026